September 5th, 2013
Rosiglitazone Revisited
Richard G. Bach, MD and John Ryan, MD
Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.
July 16th, 2012
Selections from Richard Lehman’s Literature Review: July 16th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include studies on rhythm vs. rate control in AF, thiazolidinediones and the risk for macular edema, and the effect of acadesine on morbidity and mortality associated with CABG.
NEJM Journal Watch — Recent Cardiology Articles- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events